TuHURA BIOSCIENCES, INC./NV Warrants and Rights Outstanding
TuHURA BIOSCIENCES, INC./NV (HURA) had Warrants and Rights Outstanding of $8.52 million as of 2020-06-30, per its 10-K filed 2020-09-18.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:WarrantsAndRightsOutstanding · last filed 2020-09-18
- 2020-06-30: Warrants and Rights Outstanding $8.52M.
- 2020-03-31: Warrants and Rights Outstanding $8.38M.
- 2019-12-31: Warrants and Rights Outstanding $8.31M.
- 2019-09-30: Warrants and Rights Outstanding $8.28M.
| Period end | Warrants and Rights Outstanding | Warrants and Rights Outstanding as first filed |
|---|---|---|
| 2020-06-30 | $8.52M 10-K · filed 2020-09-18 | |
| 2020-03-31 | $8.38M 10-Q · filed 2020-05-13 | |
| 2019-12-31 | $8.31M 10-Q · filed 2020-02-13 | |
| 2019-09-30 | $8.28M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $6.59M 10-K · filed 2020-09-18 | |
| 2019-03-31 | $6.06M 10-Q · filed 2019-05-14 | |
| 2018-12-31 | $6.05M 10-Q · filed 2019-02-11 | |
| 2018-09-30 | $8.26M 10-Q · filed 2018-11-13 | |
| 2018-06-30 | $8.23M 10-K · filed 2019-09-09 | |
| 2018-03-31 | $7.48M 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $7.32M 10-Q · filed 2018-02-14 | |
| 2017-09-30 | $7.32M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $4.57M 10-K · filed 2019-09-09 | |
| 2017-03-31 | $1.62M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $1.68M 10-Q · filed 2017-02-10 | |
| 2016-09-30 | $1.68M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $1.66M 8-K · filed 2019-06-03 | |
| 2016-03-31 | $1.19M 10-Q · filed 2016-05-12 | |
| 2015-12-31 | $971.74K 10-Q · filed 2016-02-12 | |
| 2015-09-30 | $777.25K 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $89.43K 10-K · filed 2017-09-27 | $6.14M 10-K · filed 2015-09-03 |
| 2015-03-31 | $89.43K 10-Q · filed 2016-05-12 | $6.14M 10-Q · filed 2015-05-15 |
| 2014-12-31 | $138.81K 10-Q · filed 2016-02-12 | $6.19M 10-Q · filed 2015-02-12 |
| 2014-09-30 | $138.81K 10-Q · filed 2015-11-16 | $6.19M 10-Q · filed 2014-11-07 |
| 2014-06-30 | $151.45K 10-K · filed 2016-09-13 | $6.20M 10-K · filed 2014-08-28 |
| 2014-03-31 | $6.20M 10-Q · filed 2014-05-15 | |
| 2013-12-31 | $6.20M 10-K · filed 2014-08-28 | |
| 2013-09-30 | $6.20M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $6.44M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $6.44M 10-Q · filed 2013-05-15 | |
| 2012-12-31 | $153.11K 10-K · filed 2014-08-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |